Yuasa, Naoki
Harada, Tomonari
Kagami, Kazuki
Ishii, Hideki
Obokata, Masaru http://orcid.org/0000-0002-5473-0688
Article History
Received: 4 April 2024
Accepted: 30 April 2024
First Online: 26 June 2024
Declarations
:
: Dr. Obokata received speaker honoraria from Novartis, Otsuka Pharmaceutical, AstraZeneca Inc., Eli Lilly, and Nippon Boehringer-Ingelheim. Dr. Ishii received lecture fees from AstraZeneca Inc., Bayer Pharmaceutical Co., Ltd., Boehringer Ingelheim Japan, Bristol-Myers Squibb Inc., Daiichi-Sankyo Pharma Inc., MSD K.K., Mitsubishi Tanabe Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., Novartis Japan, and Pfizer Japan Inc. All other authors declare no conflicts of interest.
: This is a review paper and does not include human or animal studies.